The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Metabolic syndrome and chronic kidney disease
Abstract
PURPOSE OF REVIEW: The association of the metabolic syndrome (MetS) with cardiovascular risk, mortality, type 2 diabetes mellitus, stroke, nonfatty liver disease and gout is well known. However, the association of the MetS with chronic kidney disease (CKD) is now emerging. This review discusses the epidemiology, pathology and potential mechanisms for the relationship of MetS with CKD. RECENT FINDINGS: Studies show that patients with MetS have a 2.5-fold higher risk of developing CKD. The risk of microalbuminuria is also increased two-fold in the MetS. Renal dysfunction becomes apparent long before the appearance of hypertension or diabetes in MetS. Compared with healthy controls, patients with MetS have increased microvascular disease-tubular atrophy, interstitial fibrosis, arterial sclerosis and global and segmental sclerosis. Studies suggest that the renal fibrosis seen in MetS might be caused by a constellation of insulin resistance, hypertension, dyslipidemias and inflammation, and result in a heightened expression of adipocytokines, angiotensin and inflammatory cytokines such as interleukin-6 and tumour necrosis factor-alpha. SUMMARY: Despite the strong association of MetS with CKD, a causal relationship has not been proven. More studies are needed to precisely elucidate the mechanisms that might lead upstream factors such as insulin resistance, hypertension, dyslipidemia and inflammation to cause renal fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2444 · Cited by 1,488
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359
Obesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D'Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,286
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. Z. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,000
Wolf, G., Chen, S., Han, D. C., & Ziyadeh, F. N. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29865 · Cited by 871
Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
Kurella, M., Lo, J. C., & Chertow, G. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010106 · Cited by 709
Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor
Grundy, S. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0513 · Cited by 658
Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02180311 · Cited by 553
Association Between Body Mass Index and CKD in Apparently Healthy Men
Gelber, R. P., Kurth, T., Kausz, A. T., Manson, J. E., Buring, J. E., Levey, A. S., & Gaziano, J. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.015 · Cited by 460
Resnick, H. E., Jones, K., Ruotolo, G., Jain, A. K., Henderson, J., Lu, W., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.861 · Cited by 427
Obesity and Prevalent and Incident CKD: The Hypertension Detection and Follow-Up Program
Kramer, H., Luke, A., Bidani, A., Cao, G., Cooper, R., & McGee, D. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.06.007 · Cited by 414
Wolf, G., Hamann, A., Han, D. C., Helmchen, U., Thaiss, F., Ziyadeh, F. N., & Stahl, R. A. K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00626.x · Cited by 391
Lteif, A. A., Han, K., & Mather, K. J. (2005) · Circulation · doi:10.1161/circulationaha.104.520130 · Cited by 308
Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity
Carlyle, M., Jones, O. B., Kuo, J. J., & Hall, J. E. (2002) · Hypertension · doi:10.1161/hy0202.104398 · Cited by 292
The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.
Kasiske, B. L., O'Donnell, M. P., & Keane, W. F. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i110 · Cited by 263
Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy
Wang, S., Denichilo, M., Brubaker, C., & Hirschberg, R. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00776.x · Cited by 208
Metabolic syndrome and chronic kidney disease in Okinawa, Japan
Tanaka, H., Shiohira, Y., Uezu, Y., Higa, A., & Iseki, K. (2006) · Kidney International · doi:10.1038/sj.ki.5000050 · Cited by 205
Han, D. C., Isono, M., Chen, S., Casaretto, A., Hong, S. W., Wolf, G., & Ziyadeh, F. N. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041315.x · Cited by 161
Moreno‐Manzano, V., Ishikawa, Y., Lucio-Cazaña, F. J., & Kitamura, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12684 · Cited by 146
Cardiovascular Morbidity and Mortality of the Metabolic Syndrome
Obunai, K., Jani, S., & Dangas, G. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.003 · Cited by 134
Othman, M. A., Kawar, B., & Nahas, A. M. E. (2009) · Nephron Clinical Practice · doi:10.1159/000228071 · Cited by 129
Glomerular volume and renal histology in obese and non-obese living kidney donors
Rea, D. J., Heimbach, J. K., Grande, J. P., Textor, S. C., Taler, S. J., Prieto, M., Larson, T. S., Cosío, B. G., & Stegall, M. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001799 · Cited by 125
Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional Study
Alexander, M. P., Patel, T. V., Farag, Y. M. K., Flórez, A., Rennke, H. G., & Singh, A. K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.01.255 · Cited by 118
Self-citationMassive obesity and the kidney. A morphologic and statistical study.
Cohen, A. H. (1975) · PubMed · Cited by 91
Raimundo, M. R., & Lopes, J. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/747861 · Cited by 64
Lin, W.-Y., Liu, C. S., Li, T.-C., Lin, T., Chen, W. W., Chen, C.-C., Li, C. I., & Lin, C. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.073601 · Cited by 46
Obesity, inflammation, and kidney disease
Navarro-Díaz, M., Serra, A., López, D., Granada, M., Bayés, B., & Romero, R. (2008) · Kidney International · doi:10.1038/ki.2008.518 · Cited by 46
Inflammation modifies lipid-mediated renal injury
Ruan, X. Z., Varghese, Z., & Moorhead, J. F. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.1.27 · Cited by 40
Perlstein, T. S., Gerhard-Herman, M., Hollenberg, N. K., Williams, G. H., & Thomas, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091026 · Cited by 39 · cited 3×
“Han DC, Isono M, Chen S, et al. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression.”
BackgroundAlbuminuria and Chronic Kidney Disease in Association With the Metabolic Syndrome
Ninomiya, T., & Kiyohara, Y. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.05734.x · Cited by 29
Metabolic syndrome and chronic kidney disease
Bhowmik, D. M., & Tiwari, S. (2008) · Indian Journal of Nephrology · doi:10.4103/0971-4065.41279 · Cited by 24
Cited by
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159
Cardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D. J., & Mather, K. J. (2017) · Translational Research · doi:10.1016/j.trsl.2017.01.001 · Cited by 568
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
Haarhaus, M., Brandenburg, V., Kalantar-Zadeh, K., Stenvinkel, P., & Magnusson, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.60 · Cited by 316
Metabolic syndrome: a sympathetic disease?
Schlaich, M., Straznicky, N., Lambert, E., & Lambert, G. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70033-6 · Cited by 171
Association of metabolic syndrome and chronic kidney disease
Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155
Metadata
- Authors
- Singh, A. K., & Kari, J. A.
- Venue
- Current Opinion in Nephrology and Hypertension
- Published
- 2013-03
- Volume
- 22
- Issue
- 2
- Pages
- 198-203
- ISSN
- 1062-4821 (ISSN-L)
- OpenAlex
- W2057751659
- Cited by
- 298
- References
- 40
- FWCI
- 35.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.